Can allergy shots work as well for kids as adults? new study aims to find out.
NCT ID NCT05186025
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This 5-year study is looking at how well a year-round allergy treatment (MATA trees or MATA grass) works for children and adults with pollen allergies, including hay fever and mild asthma. Researchers want to see if the treatment is as effective in kids as it is in adults. About 320 participants aged 5 and older will track their symptoms and medication use during pollen seasons.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- MATA trees or MATA grass (modified allergen extracts adsorbed to microcrystalline tyrosine)
- What this could lead to
- If successful, this could confirm that a shorter, year-round allergy treatment works equally well for children and adults, offering a convenient option for managing pollen allergies.
- What could go wrong
- This is an observational study, not a controlled trial, so results may be less reliable. It also does not test a new treatment, but rather compares how well an existing one works in different age groups.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALLERGIC ASTHMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Universitätsklinikum Augsburg
Augsburg, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Allergy shots may unlock better asthma control by targeting hidden immune signals
- Experimental antibodies aim to block cat allergy eye itch
- Eye insert could ease allergy symptoms for contact lens wearers
- New asthma drug JYB1904 shows promise in early trial
- Cleveland clinic launches asthma research to develop better tests and treatments
- New eye drops zap allergy itch in just minutes